Related Experiment Video
Updated: Jun 11, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Evidence That Long-Term Treatment Prevents Tissue Oxidative Damage in Patients With Inherited Disorders of the
Bianca Gomes Dos Reis1,2, Graziela Schmitt Becker2, Desiree Padilha Marchetti2
1Departamento de Análises Clínicas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Insights
Propionic and methylmalonic acidemias are genetic disorders. Long-term treatment with a restricted protein diet and L-carnitine supplementation reduces oxidative damage markers in affected patients.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Propionic acidemia (PAcidemia) and methylmalonic acidemia (MMAcidemia) are genetic metabolic disorders.
- These conditions cause severe neonatal metabolic decompensation and encephalopathic episodes.
- Therapeutic management is critical for patient survival and prognosis.
Purpose of the Study:
- To investigate the long-term effects of a restricted protein diet with L-carnitine (LC) supplementation on oxidative damage markers.
- To assess the impact of this therapy on lipid, protein, and DNA/RNA oxidative damage in PAcidemia and MMAcidemia patients.
- To explore the role of oxidative stress in tissue damage and its modulation by LC therapy.
Main Methods:
- Measurement of urinary isoprostanes (lipid damage), di-tyrosine (protein damage), and oxidized guanine species (DNA/RNA damage).
- Quantification of NO products (nitrate plus nitrite) in patients.
- Comparison of markers in untreated patients, short-term treated patients, and long-term treated patients against controls.
Main Results:
- Untreated patients showed significantly increased levels of isoprostanes, di-tyrosine, and oxidized guanine species compared to controls.
- Oxidative damage markers were attenuated after short-term treatment.
- Markers normalized after prolonged L-carnitine and restricted protein therapy.
Conclusions:
- Long-standing treatment with a restricted protein diet and L-carnitine protects against oxidative damage in propionate pathway disorders.
- This therapy likely reduces metabolite accumulation and associated toxicity.
- Further research is needed to correlate oxidative stress levels with clinical outcomes in affected patients.
Abstract:
Propionic and methylmalonic acidemias (PAcidemia and MMAcidemia, respectively) are genetic disorders clinically characterized by metabolic decompensation associated with life-threatening encephalopathic episodes in the neonatal period. Adequate and rapid therapeutic management is essential for patients' survival and prognosis. In this study, a restricted protein diet associated with L-carnitine (LC) supplementation was shown to decrease mortality and morbidity in patients affected by these disorders probably by decreasing the accumulation of the major metabolites and therefore their toxicity. Since oxidative stress was proposed as a contributing mechanism of tissue damage in PAcidemia and MMAcidemia and LC has potent antioxidant properties, our objective in this work was to investigate the effects of a long-term therapy consisting of reduced protein intake associated with LC supplementation on oxidative damage markers in patients affected by these diseases. We measured urinary isoprostanes, di-tyrosine, and oxidized guanine species, which reflect oxidative damage to lipids, proteins, and DNA/RNA, respectively, as well as the concentrations of NO products (nitrate plus nitrite) in patients untreated or submitted to short-term or a long-term treatment. Results revealed significant increases of isoprostanes, di-tyrosine, and oxidized guanine species, as well as a moderate nonsignificant increase of NO levels in the untreated patients, relatively to controls. Furthermore, these altered markers were attenuated after short-term treatment and normalized after prolonged treatment. In conclusion, data from this work show for the first time that long-standing treatment of patients with disorders of the propionate pathway can protect against oxidative damage. However, it remains to be elucidated whether oxidative stress identified in this study directly correlates with the clinical conditions of the affected patients.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Peroxisomes

